Europe - EBR:BTLS - BE0974386188 - Common Stock
The current stock price of BTLS.BR is 4.925 EUR. In the past month the price increased by 1.46%. In the past year, price increased by 59.67%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SDF.DE | K+S AG-REG | N/A | 1.95B | ||
| OCI.AS | OCI NV | 0.16 | 691.15M | ||
| ALFLO.PA | FLORENTAISE SA | N/A | 5.20M |
Biotalys NV engages in the development of sustainable crop protection products. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 63 full-time employees. The company went IPO on 2021-07-02. AGROBODY Foundry is a product of this company that provides crop protection products, based on active ingredients in combination with Agrobodies as formulation agents. The company develops technology for sustainable crop protection. The company offers tools to prevent crop loss while extending post-harvest protection and reducing food waste. This company provides protein-based biocontrol solutions. Biotalys allows biocontrol solutions to tackle a wide range of crop pests and diseases. This company has built a product pipeline against key pests and diseases known as EvocaTM. The company also has a range of products pipeline of BioFungicides, BioInsecticides and BioBactericides.
BIOTALYS NV
Buchtenstraat 11
Ghent OOST-VLAANDEREN BE
Employees: 63
Phone: 3292745400
Biotalys NV engages in the development of sustainable crop protection products. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 63 full-time employees. The company went IPO on 2021-07-02. AGROBODY Foundry is a product of this company that provides crop protection products, based on active ingredients in combination with Agrobodies as formulation agents. The company develops technology for sustainable crop protection. The company offers tools to prevent crop loss while extending post-harvest protection and reducing food waste. This company provides protein-based biocontrol solutions. Biotalys allows biocontrol solutions to tackle a wide range of crop pests and diseases. This company has built a product pipeline against key pests and diseases known as EvocaTM. The company also has a range of products pipeline of BioFungicides, BioInsecticides and BioBactericides.
The current stock price of BTLS.BR is 4.925 EUR. The price increased by 1.13% in the last trading session.
BTLS.BR does not pay a dividend.
BTLS.BR has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
BTLS.BR stock is listed on the Euronext Brussels exchange.
9 analysts have analysed BTLS.BR and the average price target is 7.58 EUR. This implies a price increase of 53.95% is expected in the next year compared to the current price of 4.925.
ChartMill assigns a technical rating of 10 / 10 to BTLS.BR. When comparing the yearly performance of all stocks, BTLS.BR is one of the better performing stocks in the market, outperforming 91.91% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to BTLS.BR. While BTLS.BR seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months BTLS.BR reported a non-GAAP Earnings per Share(EPS) of -0.41. The EPS increased by 18.96% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -51.18% | ||
| ROE | -74.88% | ||
| Debt/Equity | 0.16 |
9 analysts have analysed BTLS.BR and the average price target is 7.58 EUR. This implies a price increase of 53.95% is expected in the next year compared to the current price of 4.925.
For the next year, analysts expect an EPS growth of 1.76% and a revenue growth -52% for BTLS.BR